社区获得的多药耐药性肺炎,细菌病和传染性内心炎:一个病例报告
Basavaraj Jatteppanavar1, Arnab Choudhury1, Prasan Kumar Panda2
1Department of Medicine, All India Institute of Medical Sciences, Rishikesh 249203, India.
World journal of critical care medicine
|April 18, 2024
概括
多药耐药 (MDR) 细菌会导致严重的肺炎,血液感染 (细菌病) 和心脏膜感染 (内心炎). 早期诊断和治疗对于预防这些耐药性感染导致的死亡至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 关键护理医学 关键护理医学
背景情况:
- 全球多药耐药 (MDR) 和广泛耐药 (XDR) 细菌的增加对患者构成重大威胁.
- 抗菌素耐药性需要提高临床意识和诊断能力.
研究的目的:
- 报告由于社区获得的MDR Staphylococcus aureus导致的严重疾病和死亡病例.
- 强调MDR感染所带来的临床意识和管理挑战.
主要方法:
- 一个年轻的男性患者的病例报告,他的健康状况迅速恶化.
- 诊断工作包括血液检测,成像和微生物培养.
- 治疗涉及广泛的抗生素.
主要成果:
- 患者呈现出暗示热带发烧的症状,但测试结果为阴性.
- 诊断出感染性内心炎,甲素耐药黄金葡萄球菌 (MRSA) 细菌病,以及社区获得的肺炎.
- 尽管积极的抗生素治疗,患者经历了致命的结局.
结论:
- 强调必须提高人们对MDR社区获得的肺炎,细菌血症和内心炎的认识.
- 强调早期发现病原体和及时接受抗生素治疗的重要性,以预防死亡率.
- 强调全球需要对社区获得的MDR/XDR病原体进行根本原因分析.
相关概念视频
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K
01:30Pneumonia I: Introduction
230
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
230
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324